Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FDA new drug approvals in Q1 2023.
Urquhart L. Urquhart L. Nat Rev Drug Discov. 2023 May;22(5):346. doi: 10.1038/d41573-023-00065-1. Nat Rev Drug Discov. 2023. PMID: 37055583 No abstract available.
FDA new drug approvals in Q2 2023.
Urquhart L. Urquhart L. Nat Rev Drug Discov. 2023 Aug;22(8):614. doi: 10.1038/d41573-023-00117-6. Nat Rev Drug Discov. 2023. PMID: 37433940 No abstract available.
FDA new drug approvals in Q1 2019.
Urquhart L. Urquhart L. Nat Rev Drug Discov. 2019 Apr 10. doi: 10.1038/d41573-019-00070-3. Online ahead of print. Nat Rev Drug Discov. 2019. PMID: 31048810 No abstract available.
FDA new drug approvals in Q2 2019.
Urquhart L. Urquhart L. Nat Rev Drug Discov. 2019 Jul;18(8):575. doi: 10.1038/d41573-019-00121-9. Nat Rev Drug Discov. 2019. PMID: 31367061 No abstract available.
FDA new drug approvals in Q3 2019.
Urquhart L. Urquhart L. Nat Rev Drug Discov. 2019 Oct;18(11):816. doi: 10.1038/d41573-019-00177-7. Nat Rev Drug Discov. 2019. PMID: 31673140 No abstract available.
FDA new drug approvals in Q1 2020.
Urquhart L. Urquhart L. Nat Rev Drug Discov. 2020 May;19(5):299. doi: 10.1038/d41573-020-00074-4. Nat Rev Drug Discov. 2020. PMID: 32296148 No abstract available.
FDA new drug approvals in Q2 2020.
Urquhart L. Urquhart L. Nat Rev Drug Discov. 2020 Aug;19(8):503. doi: 10.1038/d41573-020-00129-6. Nat Rev Drug Discov. 2020. PMID: 32651466 No abstract available.
50 results